Medicine

Projects

Projects per year 1975 1989 2002 2005 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2025

• 25 Not started
• 62 Active
• 872 Finished

Projects per year

Search results

• Finished

  Exhaled small RNA biomarkers to detect and monitor airway disease

  Loudig, O. D. & Spivack, S. D.

  1/1/21 → 12/31/21

  Project: Research project

  • Biomarkers 100%
  • Exosomes 90%
  • Chronic Obstructive Pulmonary Disease 85%
  • Asthma 74%
  • High-Throughput Nucleotide Sequencing 73%

• Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia

  George, C. J.

  9/15/20 → 5/31/22

  Project: Research project

  • Cognitive Dysfunction 100%
  • Angiotensin-Converting Enzyme Inhibitors 85%
  • Gait 66%
  • Retirement 41%
  • Organized Financing 41%

• Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia

  George, C. J.

  National Institute on Aging

  9/15/20 → 5/31/21

  Project: Research project

  • Angiotensin-Converting Enzyme Inhibitors 100%
  • Cognitive Dysfunction 96%
  • Gait 64%
  • Dementia 63%
  • Retirement 40%

• Th2A cells mediate outcomes of aspirin-exacerbated respiratory disease

  Jerschow, E.

  9/3/20 → 8/31/21

  Project: Research project

  • Aspirin 100%
  • Th2 Cells 66%
  • Prostaglandin D2 62%
  • Nasal Polyps 30%
  • prostaglandin R2 D-isomerase 14%

• Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies

  Adedimeji, A. A., Anastos, K. & Anastos, K.

  9/1/20 → 8/31/21

  Project: Research project

  • Rwanda 100%
  • Democratic Republic of the Congo 42%
  • Military 24%
  • grant 14%
  • productivity 14%

• Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies

  Adedimeji, A. A., Anastos, K., Mutesa, L., Yotebieng, M. & Anastos, K. M.

  National Cancer Institute

  9/1/20 → 5/31/22

  Project: Research project

  • Rwanda 100%
  • Democratic Republic of the Congo 90%
  • HIV 49%
  • Neoplasms 22%
  • Anus Neoplasms 15%

• Role of HCAR1 in glucose homeostasis

  Jo, Y.

  8/15/20 → 8/31/21

  Project: Research project

  • brown adipose tissue 100%
  • receptors 57%
  • acids 37%
  • lactates 35%
  • glucose 32%

• Role of HCAR1 in glucose homeostasis

  Jo, Y.

  National Center for Advancing Translational Sciences

  8/15/20 → 8/31/21

  Project: Research project

  • brown adipose tissue 100%
  • receptors 57%
  • homeostasis 42%
  • acids 41%
  • glucose 41%

• GPR30 and hepatic cholesterol metabolism

  Wang, D. Q. H.

  National Institute of Diabetes and Digestive and Kidney Diseases

  7/10/20 → 6/30/22

  Project: Research project

  • G-Protein-Coupled Receptors 100%
  • Gallstones 99%
  • Cholesterol 67%
  • Estrogens 66%
  • Liver 42%

• Mentoring of multidisciplinary global health research in tuberculosis and HIV

  Brust, J. C. M. & Brust, J. C. M.

  National Institute of Allergy and Infectious Diseases

  7/2/20 → 6/30/22

  Project: Research project

  • Mentoring 100%
  • Tuberculosis 97%
  • Global Health 91%
  • HIV 68%
  • Mentors 59%

• AIF1/Iba1 in microglial function and stroke

  Sibinga, N. E. S.

  7/1/20 → 6/30/22

  Project: Research project

  • Stroke 100%
  • Microglia 89%
  • Wounds and Injuries 42%
  • Inflammation Mediators 18%
  • Cell Lineage 15%

• AIF1/Iba1 in microglial function and stroke

  Nandi, S. & Sibinga, N. E. S.

  National Institute of Neurological Disorders and Stroke

  7/1/20 → 6/30/22

  Project: Research project

  • Stroke 100%
  • Microglia 94%
  • Wounds and Injuries 44%
  • Inflammation Mediators 19%
  • Cell Lineage 16%

• Trajectories and modifiable risk factors of brain, gait, and cognitive decline in aging and pre-dementia

  Blumen, H. M.

  6/15/20 → 3/31/22

  Project: Research project

  • Gait 100%
  • Dementia 51%
  • Cognitive Dysfunction 50%
  • Brain 34%
  • Social Networking 29%

• Trajectories and modifiable risk factors of brain, gait, and cognitive decline in aging and pre-dementia

  Blumen, H. M.

  National Institute on Aging

  6/15/20 → 3/31/21

  Project: Research project

  • Gait 100%
  • Dementia 69%
  • Cognitive Dysfunction 67%
  • Brain 42%
  • Social Networking 30%

• Regulation of the TGF-beta superfamily in the remodeling and failing heart

  Frangogiannis, N. G.

  4/3/20 → 3/31/22

  Project: Research project

  • Cardiac Myocytes 100%
  • Pressure 69%
  • Fibroblasts 59%
  • Heart 52%
  • Macrophages 47%

• Regulation of the TGF-beta superfamily in the remodeling and failing heart

  Frangogiannis, N. G.

  National Heart, Lung, and Blood Institute

  4/3/20 → 3/31/22

  Project: Research project

  • Cardiac Myocytes 100%
  • Pressure 69%
  • Transforming Growth Factor beta 69%
  • Heart 63%
  • Fibroblasts 59%

• Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living

  Akiyama, M. J.

  NATIONAL INSTITUTE ON DRUG ABUSE

  4/1/20 → 3/31/21

  Project: Research project

  • Hepacivirus 100%
  • Criminal Law 38%
  • Mentors 22%
  • Risk-Taking 18%
  • HIV 12%

• Metabolic control in vascular remodeling

  Sibinga, N. E. S.

  3/1/20 → 1/31/22

  Project: Research project

  • Smooth Muscle Myocytes 100%
  • Vascular Remodeling 73%
  • Electron Transport Complex I 56%
  • Embryonic Development 28%
  • Vascular Diseases 20%

• CHALO!: A mobile technology based intervention to accelerate HIV testing and linkage to prevention and treatment

  Patel, V. V.

  3/1/20 → 1/31/22

  Project: Research project

  • HIV 100%
  • Internet-Based Intervention 14%
  • HIV Infections 9%
  • India 9%
  • Epidemics 9%

• Cardiac Calcification and Cholesterol Efflux in Older Adults

  Bortnick, A. E.

  2/15/20 → 1/31/22

  Project: Research project

  • Cholesterol 100%
  • Calcification of Aortic Valve 72%
  • Parents 37%
  • Longevity 33%
  • Coronary Vessels 30%

• The impact of HIV on accelerated aging in the female genital tract: a pilot trial of topical estradiol to improve the vaginal microbiome and symptoms of vaginal atrophy in menopausal women with HIV

  Murphy, K. J.

  2/1/20 → 1/31/22

  Project: Research project

  • HIV 100%
  • Female Genitalia 57%
  • Dysbiosis 51%
  • Microbiota 47%
  • Inflammation 24%

• The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis

  Chan, J.

  1/16/20 → 12/31/21

  Project: Research project

  • phosphatidylinositol mannoside 100%
  • Mycobacterium tuberculosis 86%
  • Cell Wall 26%
  • Tuberculosis 21%
  • Growth 21%

• Beta Cell Intracellular Calcium and Diabetes

  Santulli, G.

  1/1/20 → 11/30/21

  Project: Research project

  • Type 2 Diabetes Mellitus 100%
  • Autophagy 48%
  • Mitophagy 45%
  • Insulin Secretion 33%
  • Endoplasmic Reticulum 31%

• Molecular regulation of gut lipid metabolism by mTOR and autophagy proteins

  Singh, R.

  9/17/19 → 8/31/21

  Project: Research project

  • Triglycerides 100%
  • Autophagy 83%
  • Endoplasmic Reticulum 53%
  • Metabolic Syndrome 34%
  • Enterocytes 29%

• Circadian Mechanisms of Diabetes Prevention in Aged mice

  Singh, R.

  National Institute on Aging

  9/15/19 → 5/31/22

  Project: Research project

  • Autophagy 100%
  • Gluconeogenesis 68%
  • Caloric Restriction 47%
  • Type 2 Diabetes Mellitus 28%
  • lysosomal proteins 27%

• Circadian Mechanisms of Diabetes Prevention in Aged mice

  Singh, R.

  9/15/19 → 5/31/22

  Project: Research project

  • Autophagy 100%
  • Gluconeogenesis 68%
  • Caloric Restriction 47%
  • Type 2 Diabetes Mellitus 28%
  • lysosomal proteins 27%

• Does Implicit Bias Influence Medical Decision-Making? Developing and Validating Novel Models and Outcome Metrics

  Gonzalez, C. M.

  National Institute on Minority Health and Health Disparities

  8/27/19 → 5/31/21

  Project: Research project

  • Clinical Decision-Making 100%
  • Racism 70%
  • Physicians 62%
  • Communication 37%
  • Research Personnel 34%

• Treat All and beyond: addressing methods, data and capacity building challenges in the African regions of IeDEA

  Anastos, K.

  8/1/19 → 7/31/20

  Project: Research project

  • Capacity Building 100%
  • Africa South of the Sahara 82%
  • Research Personnel 78%
  • National Institute of Allergy and Infectious Diseases (U.S.) 57%
  • Rwanda 54%

• Treat All and beyond: addressing methods, data and capacity building challenges in the African regions of IeDEA

  Anastos, K. & Davies, M. A.

  National Institute of Allergy and Infectious Diseases

  8/1/19 → 7/31/20

  Project: Research project

  • Capacity Building 100%
  • Africa South of the Sahara 30%
  • Research Personnel 28%
  • National Institute of Allergy and Infectious Diseases (U.S.) 21%
  • Rwanda 19%

• Antibodies, B cells and resistance to human cryptococcosis

  Pirofski, L.

  7/25/19 → 6/30/22

  Project: Research project

  • Cryptococcal Meningitis 100%
  • Immune Reconstitution Inflammatory Syndrome 41%
  • Glucans 31%
  • HIV 26%
  • B-Lymphocytes 14%

• Antibodies, B cells and resistance to human cryptococcosis

  Pirofski, L.

  National Institute of Allergy and Infectious Diseases

  7/25/19 → 6/30/22

  Project: Research project

  • Cryptococcal Meningitis 100%
  • Cryptococcosis 49%
  • Immune Reconstitution Inflammatory Syndrome 41%
  • B-Lymphocytes 34%
  • Glucans 31%

• STAT3 inhibition as a therapeutic strategy against MDS stem cells

  Verma, A. K. & Steidl, U. G.

  National Heart, Lung, and Blood Institute

  7/23/19 → 6/30/22

  Project: Research project

  • Myelodysplastic Syndromes 100%
  • Stem Cells 46%
  • Therapeutics 8%
  • Disease Progression 8%
  • Hematopoietic Stem Cells 5%

• Impact of multiple stigmas on HIV care continuum outcomes for key populations

  Patel, V. V.

  7/17/19 → 6/30/21

  Project: Research project

  • HIV 100%
  • India 39%
  • Retention in Care 33%
  • Continuity of Patient Care 25%
  • Mental Health 17%

• Impact of multiple stigmas on HIV care continuum outcomes for key populations

  Patel, V. V.

  NATIONAL INSTITUTE OF MENTAL HEALTH

  7/17/19 → 6/30/21

  Project: Research project

  • HIV 100%
  • Continuity of Patient Care 96%
  • India 40%
  • Population 34%
  • Retention in Care 34%

• Characteristics and protective efficacy of human antibodies against M. tuberculosis

  Achkar, J. M.

  National Institute of Allergy and Infectious Diseases

  7/1/19 → 6/30/22

  Project: Research project

  • Tuberculosis 100%
  • Mycobacterium tuberculosis 76%
  • Antibodies 51%
  • Polysaccharides 49%
  • Tuberculosis Vaccines 37%

• Characteristics and protective efficacy of human antibodies against M. tuberculosis

  Achkar, J. M.

  7/1/19 → 6/30/22

  Project: Research project

  • Tuberculosis 100%
  • Mycobacterium tuberculosis 71%
  • Polysaccharides 45%
  • Tuberculosis Vaccines 34%
  • Epitopes 20%

• Functional role of IP3 receptors in the regulation of cardiac myofibroblasts

  Santulli, G.

  7/1/19 → 6/30/21

  Project: Research project

  • Fibroblasts 100%
  • Fibrosis 77%
  • Myocardial Infarction 43%
  • Inositol 1,4,5-Trisphosphate Receptors 39%
  • Autophagy 28%

• Functional role of IP3 receptors in the regulation of cardiac myofibroblasts

  Santulli, G.

  National Heart, Lung, and Blood Institute

  7/1/19 → 6/30/22

  Project: Research project

  • Inositol 1,4,5-Trisphosphate Receptors 100%
  • Fibroblasts 91%
  • Myofibroblasts 78%
  • Fibrosis 71%
  • Myocardial Infarction 39%

• Plasmodium phospholipase A2s as potential novel drug targets

  Daily, J. P.

  6/21/19 → 5/31/21

  Project: Research project

  • Cerebral Malaria 100%
  • Brain Edema 80%
  • Endothelial Cells 53%
  • Permeability 52%
  • Plasmodium falciparum 51%

• Plasmodium phospholipase A2s as potential novel drug targets

  Daily, J. P.

  National Institute of Allergy and Infectious Diseases

  6/21/19 → 5/31/21

  Project: Research project

• Somatotropic Signaling and Resilience to Aging and Alzheimer's Disease

  Milman, S.

  4/15/19 → 1/31/22

  Project: Research project

  • Alzheimer Disease 100%
  • Aged, 80 and over 58%
  • Exome 38%
  • Autophagy 30%
  • Dementia 26%

• Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53

  Zhao, H. & Schwartz, E. L.

  4/12/19 → 3/31/22

  Project: Research project

  • Small Cell Lung Carcinoma 100%
  • Drug Therapy 17%
  • Heterografts 16%
  • Ubiquitination 13%
  • Neoplasms 11%

• Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53

  Schwartz, E. L. & Zhao, H.

  National Cancer Institute

  4/12/19 → 3/31/21

  Project: Research project

  • Small Cell Lung Carcinoma 100%
  • Drug Therapy 18%
  • Heterografts 16%
  • Ubiquitination 13%
  • Neoplasms 12%

• Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)

  Sharma, A. & Anastos, K.

  4/1/19 → 3/31/21

  Project: Research project

  • HIV 100%
  • Cardiovascular Diseases 29%
  • Cohort Studies 27%
  • Comorbidity 18%
  • Microbiota 15%

• Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)

  Anastos, K. & Sharma, A.

  National Heart, Lung, and Blood Institute

  4/1/19 → 3/31/22

  Project: Research project

  • HIV 100%
  • Cohort Studies 95%
  • Acquired Immunodeficiency Syndrome 72%
  • Comorbidity 34%
  • Cardiovascular Diseases 20%

• IgM in the regulation of TB immunity

  Chan, J.

  2/15/19 → 1/31/22

  Project: Research project

  • Mycobacterium tuberculosis 100%
  • Immunoglobulin M 98%
  • Germinal Center 74%
  • Humoral Immunity 24%
  • B-Lymphocytes 24%

• Hemolysis and Platelet Activation during Continuous Flow Mechanical Circulatory Support

  Saeed, O.

  1/15/19 → 12/31/21

  Project: Research project

  • Hemolysis 100%
  • Platelet Activation 64%
  • Platelet Aggregation 52%
  • Thrombosis 34%
  • Sildenafil Citrate 27%

• Cooperative Research Agreements Related to the World Trade Center Health Program (U01)

  Verma, A. K.

  1/1/19 → 6/30/20

  Project: Research project

• Developmental PBDE exposure, gut microbiome, and diabetes

  Mani, S.

  1/1/19 → 12/31/21

  Project: Research project

  • Halogenated Diphenyl Ethers 100%
  • Gastrointestinal Microbiome 55%
  • Dysbiosis 35%
  • Indoles 30%
  • Tryptophan 30%

• Mechanisms of cardiovascular disease

  Kitsis, R. N. & Sibinga, N. E. S.

  1/1/19 → 12/31/21

  Project: Research project

  • Cardiovascular Diseases 100%
  • Molecular Biology 74%
  • Cardiologists 51%
  • Vascular Diseases 44%
  • Myocardial Ischemia 40%